<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="/i/xml/xsl_formatting_rss.xml"?>

<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">

<channel>
<title>Andor Technology Discussion</title>
<description>Andor Technology Discussion Board</description>
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion</link>

<image>
  <title>Interactive Investor</title>
  <url>http://www.iii.co.uk/icons/logos/uk_logo.gif</url>
  <link>http://www.iii.co.uk</link>
</image>



<item>
<guid isPermaLink="false">tag:iii.co.uk,2003:tst.9540391</guid>
<title>MIDAS share tip</title>
<description><![CDATA[ Hi everyone, I don't have any shares but this 'tip' in the mail  looked interesting.<br>
<A HREF="http://www.thisismoney.co.uk/money/markets/article-2129816/MIDAS-The-20-000-cameras-loyal-buyers.html" onclick="return redirectcheck('http://www.thisismoney.co.uk/money/markets/article-2129816/MIDAS-The-20-000-cameras-loyal-buyers.html<br>')" target="_new" rel="nofollow">http://www.thisismoney.co.uk/money/markets/article-2129816/MIDAS-The-20-000-cameras-loyal-buyers.html<br></A>
 By OilPrince ]]></description> 
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion&amp;id=9540391&amp;action=detail</link>
<pubDate>Mon, 16 Apr 2012 08:52:00 GMT</pubDate>
<dc:creator>OilPrince</dc:creator>
</item>

<item>
<guid isPermaLink="false">tag:iii.co.uk,2003:tst.9499473</guid>
<title>Drop after Drop</title>
<description><![CDATA[ Does anyone know why AND has droppend in nearly every trading session for the last 10 days. 3% plus today and there was nothing in the annoucment to justify this.<br>
<br>
someone enlighten me else I think I might be selling to lock in the profits By ttquattro ]]></description> 
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion&amp;id=9499473&amp;action=detail</link>
<pubDate>Mon, 02 Apr 2012 14:21:00 GMT</pubDate>
<dc:creator>ttquattro</dc:creator>
</item>

<item>
<guid isPermaLink="false">tag:iii.co.uk,2003:tst.9466926</guid>
<title>AND</title>
<description><![CDATA[ Hi folks,<br>
<br>
Just posted Part IX of The Great Irish Share Valuation Project, including my fair valuation and commentary about Andor:<br>
<br>
<A HREF="http://wexboy.wordpress.com/2012/03/22/the-great-irish-share-valuation-project-ix/" onclick="return redirectcheck('http://wexboy.wordpress.com/2012/03/22/the-great-irish-share-valuation-project-ix/<br>')" target="_new" rel="nofollow">http://wexboy.wordpress.com/2012/03/22/the-great-irish-share-valuation-project-ix/<br></A>
<br>
Cheers,<br>
<br>
Wexboy By Wexboy ]]></description> 
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion&amp;id=9466926&amp;action=detail</link>
<pubDate>Thu, 22 Mar 2012 23:34:00 GMT</pubDate>
<dc:creator>Wexboy</dc:creator>
</item>

<item>
<guid isPermaLink="false">tag:iii.co.uk,2003:tst.9434372</guid>
<title>Mark Slater</title>
<description><![CDATA[ Mark Slater rates Andor as a core holding in his top performing growth fund. Providing growth in a low growth environment ...<br>
<br>
&quot;We like Hutchison China Meditech, our largest holding for a long time. Its key activity is health care in China. Oxford Instruments is typical of the type of company we like &#150; nichey but global. It is heavily exposed to the nanotechnology space, where spending is being prioritised all over the world. Similarly, Andor Technology makes cameras with very high specifications, primarily for research laboratories.<br>
<br>
These companies are not directly exposed to economic problems at large. They are either in demand or they're not &#150; at the moment, they are.&quot;<br>
<br>
see <A HREF="http://www.telegraph.co.uk/finance/personalfinance/investing/9140062/UK-economy-may-not-recover-for-more-than-five-years.html" onclick="return redirectcheck('http://www.telegraph.co.uk/finance/personalfinance/investing/9140062/UK-economy-may-not-recover-for-more-than-five-years.html<br>')" target="_new" rel="nofollow">http://www.telegraph.co.uk/finance/personalfinance/investing/9140062/UK-economy-may-not-recover-for-more-than-five-years.html<br></A>
<br>
Worth picking up if they fall below a fiver IMO.<br>
 By DrSlowly ]]></description> 
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion&amp;id=9434372&amp;action=detail</link>
<pubDate>Thu, 15 Mar 2012 09:48:00 GMT</pubDate>
<dc:creator>DrSlowly</dc:creator>
</item>

<item>
<guid isPermaLink="false">tag:iii.co.uk,2003:tst.9371846</guid>
<title>Hyperspectral imaging system for skin cancer screening relies on Andor http://bit.ly/AtEs89</title>
<description><![CDATA[ 03/01/2012 | 08:12am<br>
Andor Technology plc : Hyperspectral imaging system for skin cancer screening relies on Andor<br>
<A HREF="http://bit.ly/AtEs89" onclick="return redirectcheck('http://bit.ly/AtEs89')" target="_new" rel="nofollow">http://bit.ly/AtEs89</A> By SpikeyDT ]]></description> 
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion&amp;id=9371846&amp;action=detail</link>
<pubDate>Thu, 01 Mar 2012 12:18:00 GMT</pubDate>
<dc:creator>SpikeyDT</dc:creator>
</item>

<item>
<guid isPermaLink="false">tag:iii.co.uk,2003:tst.9364370</guid>
<title>The Expert View..</title>
<description><![CDATA[ The Expert View<br>
by Harry Brooks on Feb 29, 2012 at 05:01<br>
<A HREF="http://bit.ly/xGB39t" onclick="return redirectcheck('http://bit.ly/xGB39t')" target="_new" rel="nofollow">http://bit.ly/xGB39t</A> By SpikeyDT ]]></description> 
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion&amp;id=9364370&amp;action=detail</link>
<pubDate>Wed, 29 Feb 2012 05:26:00 GMT</pubDate>
<dc:creator>SpikeyDT</dc:creator>
</item>

<item>
<guid isPermaLink="false">tag:iii.co.uk,2003:tst.9343256</guid>
<title>Launches EX2 Technology Offering Extended EMCCD Sensitivity</title>
<description><![CDATA[ Andor Technology plc : Andor Launches EX2 Technology Offering Extended EMCCD Sensitivity<br>
Belfast, Northern Ireland, 23rd February 2012 - <br>
<A HREF="http://bit.ly/zzVPNs" onclick="return redirectcheck('http://bit.ly/zzVPNs')" target="_new" rel="nofollow">http://bit.ly/zzVPNs</A> By SpikeyDT ]]></description> 
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion&amp;id=9343256&amp;action=detail</link>
<pubDate>Thu, 23 Feb 2012 20:02:00 GMT</pubDate>
<dc:creator>SpikeyDT</dc:creator>
</item>

<item>
<guid isPermaLink="false">tag:iii.co.uk,2003:tst.9328713</guid>
<title>Belfast Telegraph</title>
<description><![CDATA[ Company Snapshot: Andor Technology plc.<br>
Andor continues its success story<br>
By John Simpson<br>
Tuesday, 21 February 2012<br>
<A HREF="http://bit.ly/xazUl8" onclick="return redirectcheck('http://bit.ly/xazUl8')" target="_new" rel="nofollow">http://bit.ly/xazUl8</A> By SpikeyDT ]]></description> 
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion&amp;id=9328713&amp;action=detail</link>
<pubDate>Tue, 21 Feb 2012 16:38:00 GMT</pubDate>
<dc:creator>SpikeyDT</dc:creator>
</item>

<item>
<guid isPermaLink="false">tag:iii.co.uk,2003:tst.9310833</guid>
<title>DSD now supported by Metamorph NX</title>
<description><![CDATA[ Andor Technology plc : Andor Revolution DSD now supported by Metamorph NX<br>
Belfast, 16 February 2012 - <br>
<A HREF="http://bit.ly/w3U3RR" onclick="return redirectcheck('http://bit.ly/w3U3RR')" target="_new" rel="nofollow">http://bit.ly/w3U3RR</A> By SpikeyDT ]]></description> 
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion&amp;id=9310833&amp;action=detail</link>
<pubDate>Fri, 17 Feb 2012 16:22:00 GMT</pubDate>
<dc:creator>SpikeyDT</dc:creator>
</item>

<item>
<guid isPermaLink="false">tag:iii.co.uk,2003:tst.9141423</guid>
<title>Pioneering publication reports first ratiometric</title>
<description><![CDATA[ Andor Technology plc : Pioneering publication reports first ratiometric, single-protein red fluorescent pH sensor in live neurons<br>
Harvard Medical School team uses Andor Revolution DSD confocal for simultaneous measurement of intracellular pH and ATP in live cells<br>
Belfast, Northern Ireland, 10 January 2011<br>
<A HREF="http://bit.ly/Aw8Ife" onclick="return redirectcheck('http://bit.ly/Aw8Ife')" target="_new" rel="nofollow">http://bit.ly/Aw8Ife</A> By SpikeyDT ]]></description> 
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion&amp;id=9141423&amp;action=detail</link>
<pubDate>Tue, 10 Jan 2012 11:15:00 GMT</pubDate>
<dc:creator>SpikeyDT</dc:creator>
</item>

<item>
<guid isPermaLink="false">tag:iii.co.uk,2003:tst.9041827</guid>
<title>Andor pairing can tell their Ardberg from their Edradour</title>
<description><![CDATA[ 12/07/2011 | 07:36 am<br>
Andor Technology plc : Andor pairing can tell their Ardberg from their Edradour<br>
<A HREF="http://bit.ly/rrwq7X" onclick="return redirectcheck('http://bit.ly/rrwq7X')" target="_new" rel="nofollow">http://bit.ly/rrwq7X</A> <br>
St Andrew's University researchers use laser-based near-infrared (NIR) spectroscopy to characterise whiskies and identify fakes<br>
<br>
7th December 2011, Belfast, UK: If you can't tell your Bruichladdich from your Irn-Bru, or your Glenfiddich from your Glenmorangie, help is at hand from the physics department at St Andrews University. Praveen Ashok, Kishan Dholakia and Bavishna Praveen of the optical manipulation group have developed a microfluidic device that can not only detect counterfeit whisky samples but also characterise genuine samples by brand, age and, even, cask.<br>
<br>
Quality standardisation for Scotch whisky is assessed using alcohol content, colour consistency and flavour. Low alcohol content is a primary indicator of fake whisky but the distinctive flavour, which is determined by its congener profile, is very difficult to mimic. This profile is governed by organic compounds formed during fermentation and during maturation in wooden casks. Amounting to less than 1% of the total volume, these include organic acids, higher order alcohols, esters, and aldehydes and wood extracts, such as tannin, acid and colouring matters.<br>
<br>
The team used an alignment-free, optical fibre based, optofluidic chip to analyse 20 &micro;L samples of commercially available single malt whiskies using Near Infrared (NIR) spectroscopy. No sample preparation was involved, variation due to ethanol evaporation was eliminated by the confinement within the microfluidic channel and the analysis time of was approximately two seconds. Raman and fluorescence spectra were recorded by an Andor Shamrock SR-303i spectrometer equipped with an Andor Newton DU920P BR-DD back-illuminated, thermoelectrically-cooled CCD camera.<br>
<br>
&quot;The Raman spectra of the whisky samples is dominated by peaks corresponding to 40% ethanol and our results clearly demonstrate that the alcohol content may be predicted to a probability of more than 99%, enough to rapidly weed out the majority of fakes&quot; says Praveen Ashok. &quot;Although the congener components could not be distinguished from differences in the Raman peaks, the broad fluorescence background is markedly different for different types of whisky due to the variation in congener profiles. The result is successful classification of whiskies based upon their age, origin and cask - a skill few human palettes can match.<br>
<br>
&quot;We chose the Andor analytical instruments due to the high sensitivity of the DU920P BR-DD CCD camera and the small form factor of the Shamrock SR-303i spectrometer. While its performance is every bit as good as a bench-top system, the Shamrock's compact size and low weight lent it a degree of portability as well. This was important to us as we wanted to demonstrate the potential of a hand-held device that could be used by distilleries to quality control their production by benchmarking against a known standard. The same hand-held instrument could also be used to test for counterfeit whisky bottles and confidently deliver reliable results in seconds,&quot; concludes Ashok.<br>
<br>
&quot;The maintenance-free, deep Thermo-Electric cooling and USB connectivity of the Newton Deep-Depletion platform enables access to the highest NIR sensitive detection, not only in Research labs but also in challenging industrial environments,&quot; according to Antoine Varagnat, Product specialist at Andor. &quot;When combining the Shamrock 303 USB spectrograph with their novel Raman-based micro-fluidics system, Ashok's team were able to successfully demonstrate a very sensitive and accurate setup for the rapid characterization and sorting of liquids, This also enabled them to identify counterfeit lots of potentially valuable spirits in an industrial environment. This powerful Raman micro-fluidics technique will be of great interest for the liquid-processing industry in general, but this is also great news for Whisky aficionados around the wor By SpikeyDT ]]></description> 
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion&amp;id=9041827&amp;action=detail</link>
<pubDate>Wed, 07 Dec 2011 11:43:00 GMT</pubDate>
<dc:creator>SpikeyDT</dc:creator>
</item>

<item>
<guid isPermaLink="false">tag:iii.co.uk,2003:tst.9034383</guid>
<title> Non-invasive instrument for skin cancer screening demonstrated</title>
<description><![CDATA[ 12/05/2011 | 11:42 am<br>
<A HREF="http://www.4-traders.com/ANDOR-TECHNOLOGY-PLC-4004967/news/ANDOR-TECHNOLOGY-PLC-Non-invasive-instrument-for-skin-cancer-screening-demonstrated-13919984/" onclick="return redirectcheck('http://www.4-traders.com/ANDOR-TECHNOLOGY-PLC-4004967/news/ANDOR-TECHNOLOGY-PLC-Non-invasive-instrument-for-skin-cancer-screening-demonstrated-13919984/<br>')" target="_new" rel="nofollow">http://www.4-traders.com/ANDOR-TECHNOLOGY-PLC-4004967/news/ANDOR-TECHNOLOGY-PLC-Non-invasive-instrument-for-skin-cancer-screening-demonstrated-13919984/<br></A>
Andor Technology plc : Non-invasive instrument for skin cancer screening demonstrated<br>
<br>
Andor Newton camera powers combined RS-OCT probe capable of both morphological and biochemical characterization of skin cancers<br>
<br>
Skin cancer is the most common form of human cancer with annual rates continuing to climb from their current estimate of just over three million new cases each year. Although all skin cancers share the likelihood of a favourable outcome if early diagnosis and complete resection are achieved, diagnosis is invasive, subjective, lengthy and expensive involving expert visual inspection, biopsy and histopathology.<br>
<br>
Now, a joint US-Dutch team under the direction of Anita Mahadevan-Jansen, Vanderbilt University, US, has developed a non-invasive probe capable of both morphological and biochemical characterization of skin cancers. The portable instrument combines a Raman spectroscopy (RS) system with an Optical Coherence Tomography (OCT) device and enables sequential acquisition of co-registered OCT and RS data sets. An Andor high resolution, near-infrared-enhanced Newton camera was chosen as the core element of the Raman diagnosis module. The probe will screen large areas of skin up to 15 mm wide to a depth of 2.4 mm with OCT to visualize microstructural irregularities and perform an initial morphological analysis of lesions. The OCT images are then used to identify locations to acquire biochemically specific Raman spectra.<br>
<br>
&quot;Due to the inherently weak nature of Raman scattering and the relatively intense background autofluorescence from tissue, collection efficiency is a critical factor in the design of clinical RS probes,&quot; says Chetan A. Patil, Vanderbilt University, US. &quot;Unlike confocal approaches that emphasize axial resolution, our probe is designed to prioritize collection efficiency. The high sensitivity of the Andor Newton CCD's back-illuminated, deep-depletion, thermo-electrically cooled design is well suited to the stringent demands of in vivo Raman spectroscopy.<br>
<br>
&quot;Having demonstrated the clinical potential of the RS-OCT instrument to rapidly screen at risk patients, we are continuing to develop the dual-modal technique for other applications where non-invasive assessment of both microstructure and biochemical composition are critical to accurate assessment of pathology. The Labview software development kit, which is supplied with the camera and supported directly by Andor, was crucial in the development of our first probe and in our on-going research,&quot; concludes Patil.<br>
<br>
According to Antoine Varagnat, Product Specialist at Andor, &quot;With its high sensitivity in the NIR enabled by high Quantum Efficiency and deep TE-cooling interface, the Newton Deep-Depletion CCD platform is just the right detector for demanding clinical NIR spectral diagnosis. One also gets the benefit of long-lasting detection performance and reliability with Andor's UltraVac&#153; vacuum technology, alongside high speed acquisitions and ease of integration.&quot;<br>
<br>
Andor's modular Spectroscopy solutions encompass a wide range of high performance CCD, ICCD, EMCCD and InGaAs array detectors, as well as a comprehensive range of Research-grade spectrograph platforms. To learn more about the Newton camera series and their use in spectroscopy, please visit the Andor website . By SpikeyDT ]]></description> 
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion&amp;id=9034383&amp;action=detail</link>
<pubDate>Mon, 05 Dec 2011 15:48:00 GMT</pubDate>
<dc:creator>SpikeyDT</dc:creator>
</item>

<item>
<guid isPermaLink="false">tag:iii.co.uk,2003:tst.9004797</guid>
<title>Andor marches on</title>
<description><![CDATA[ <A HREF="http://www.investorschronicle.co.uk/2011/11/28/shares/news-and-analysis/andor-marches-on-2p3cMNM5Jg5o69UITvKbvN/article.html" onclick="return redirectcheck('http://www.investorschronicle.co.uk/2011/11/28/shares/news-and-analysis/andor-marches-on-2p3cMNM5Jg5o69UITvKbvN/article.html<br>')" target="_new" rel="nofollow">http://www.investorschronicle.co.uk/2011/11/28/shares/news-and-analysis/andor-marches-on-2p3cMNM5Jg5o69UITvKbvN/article.html<br></A>
Andor marches on<br>
By Graeme Davies, 28 November 2011<br>
<br>
Scientific imaging manufacturer Andor Technology maintained its enviable growth record by registering an impressive 14th consecutive year of compound sales growth of over 30 per cent.<br>
Andor has benefited from continued growth in its core high-end markets, where it's taking market share, coupled with an expansion of its product range into mid-range products. This resulted in growth of at least 20 per cent in every business segment and region in which Andor sells. The group enjoyed particular success in sales of bespoke systems, which more than doubled and now account for 22 per cent of total revenues. The systems offering was boosted by two acquisitions last year.<br>
Systems sales are lower margin than product or original equipment manufacturer (OEM) sales, which meant that overall gross margins dipped a little &#150; although chief executive Conor Walsh doesn't expect systems to grow beyond 30 per cent of revenues as it has the potential to cannibalise other parts of the business.<br>
Andor's order book grew &pound;400,000 on last year to &pound;13.8m. But there's relatively limited visibility in the order book and Mr Walsh admitted there are signs of nervousness, particularly in the US OEM market where there has been some de-stocking of inventories.<br>
Broker finnCap expects adjusted pre-tax profit of &pound;11.5m for 2012, and EPS of 28.6p (from &pound;9.7m and 24.8p in 2011 ).<br>
ANDOR TECHNOLOGY (AND)<br>
ORD PRICE:	550p	MARKET VALUE:	&pound;168.8m<br>
TOUCH:	545-554p	12-MONTH HIGH:	690p	LOW: 361p<br>
DIVIDEND YIELD:	nil	PE RATIO:	25<br>
NET ASSET VALUE:	128p*	NET CASH:	&pound;12.7m<br>
Year to 30 Sep	Turnover (&pound;m)	Pre-tax profit (&pound;m)	Earnings per share (p)	Dividend per share (p)<br>
2007	21.3	1.28	4.37	nil<br>
2008	24.7	1.51	4.22	nil<br>
2009	33.1	4.61	14.4	nil<br>
2010	42.7	5.81	15.7	nil<br>
2011	57.4	8.74	21.6	nil<br>
% change	+34	+50	+38	-<br>
Ex-div: -<br>
Payment: -<br>
*Includes intangible assets of &pound;16.6m, or 54p a share<br>
IC VIEW:<br>
<br>
A forward PE ratio of 19 isn't cheap, but Andor's new product launches and increased market penetration bode well for 2012 &#150; despite the challenging wider economic conditions. Long-term good value. By SpikeyDT ]]></description> 
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion&amp;id=9004797&amp;action=detail</link>
<pubDate>Mon, 28 Nov 2011 15:00:00 GMT</pubDate>
<dc:creator>SpikeyDT</dc:creator>
</item>

<item>
<guid isPermaLink="false">tag:iii.co.uk,2003:tst.9001985</guid>
<title>Results</title>
<description><![CDATA[ See news above good results       Commenting on the results Colin Walsh, Chairman, said:<br>
<br>
&quot;This has been another exceptional year for Andor and I would like to thank our teams right across the business for their dedication in delivering such a strong result.  Few other businesses can claim to have grown revenue and profit so convincingly in what remains an uncertain economic environment.  My board colleagues and I believe that Andor remains well placed to continue to deliver profitable growth, both in the short and long term, and we remain confident in our expectations for 2012.&quot; <br>
 By skytrainbkk ]]></description> 
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion&amp;id=9001985&amp;action=detail</link>
<pubDate>Mon, 28 Nov 2011 07:04:00 GMT</pubDate>
<dc:creator>skytrainbkk</dc:creator>
</item>

<item>
<guid isPermaLink="false">tag:iii.co.uk,2003:tst.8996258</guid>
<title>To create 166 new jobs in the North</title>
<description><![CDATA[ Andor Technology to create 166 new jobs in the North<br>
November 25, 2011<br>
<A HREF="http://insideireland.ie/2011/11/25/andor-technology-to-create-166-new-jobs-in-the-north-43205/" onclick="return redirectcheck('http://insideireland.ie/2011/11/25/andor-technology-to-create-166-new-jobs-in-the-north-43205/<br>')" target="_new" rel="nofollow">http://insideireland.ie/2011/11/25/andor-technology-to-create-166-new-jobs-in-the-north-43205/<br></A>
By Laura McGuigan<br>
NI Enterprise Minister Arlene Foster today welcomed the announcement that Andor Technology plc, based in west Belfast, is to create 166 new jobs in an &pound;18million investment.<br>
<br>
Invest NI has offered the company &pound;1,500,000 of support and is in discussion with the company regarding potential support for training and R&amp;D activities.<br>
<br>
<br>
<br>
Andor Technology make high performance digital cameras and associated products used for imaging and the measurement of light.<br>
<br>
It was established in 1989 as a spin-out from Queen&#146;s University and today employs over 230 staff in Northern Ireland and 321 globally.<br>
<br>
The investment is part of a five year strategy to more than double the company&#146;s turnover by growing current sales channels and expanding its portfolio of products to include mid-price cameras.<br>
<br>
Welcoming the investment, Arlene Foster said:<br>
<br>
&#147;This investment represents a major growth phase for Andor Technology and marks the acceleration of its strategic transition from a company focused on high cost products for niche and specialised markets, to a company that will capture its share of the much larger mid-price camera market.<br>
<br>
&#147;Almost all the new jobs being created will pay above the Northern Ireland private sector median with two thirds paying 25% above this level.<br>
<br>
&#147;Overall they will contribute some &pound;7.6million to the economy in salaries annually.&#148;<br>
<br>
The investment also includes a major restructuring and upgrade of Andor&#146;s existing Springvale Business Park premises plus investment in additional buildings within the Park.<br>
<br>
The company will also establish the Andor Learning and Development Academy, which is being supported by the Department for Employment and Learning (DEL) through its Assured Skills programme.<br>
<br>
&#147;Our objective has always been to be the market leader in specialist scientific cameras and through continuous investment in R&amp;D we have achieved international success in this field,&#148; said Conor Walsh, Managing Director of Andor Technology.<br>
<br>
&#147;Our ambitious strategy for growth over the next five years now includes acquisitions and targeting new market sectors.&#148; By SpikeyDT ]]></description> 
<link>http://www.iii.co.uk/investment/detail?code=cotn:AND.L&amp;display=discussion&amp;id=8996258&amp;action=detail</link>
<pubDate>Fri, 25 Nov 2011 13:40:00 GMT</pubDate>
<dc:creator>SpikeyDT</dc:creator>
</item>

</channel>
</rss>

